Date Filer Title Filing Type Shares Traded Price Total Held
September 20, 2018 Director Form 4 Open market or private purchase of non-derivative or derivative security 2,500 $2.70 18,091
September 20, 2018 Director Form 4 Open market or private purchase of non-derivative or derivative security 2,500 $2.70 14,750
November 19, 2008 Director Form 4 Open market or private purchase of non-derivative or derivative security 2,100 $2.70 122,562
November 17, 2008 Director Form 4 Open market or private purchase of non-derivative or derivative security 100 $2.60 113,462
March 17, 2009 Director, President & CEO Form 4 Open market or private purchase of non-derivative or derivative security 3,750 $2.56 60,917
May 13, 2015 Director Form 4 Open market or private purchase of non-derivative or derivative security 5,000 $2.50 60,081
November 13, 2014 Director Form 4 Open market or private purchase of non-derivative or derivative security 4,000 $2.50 23,999
December 4, 2008 Director Form 4 Open market or private purchase of non-derivative or derivative security 19,007 $2.50 43,356
November 20, 2008 VP & Chief Medical Officer Form 4 Open market or private purchase of non-derivative or derivative security 5,596 $2.50 14,000
November 19, 2008 VP & Chief Medical Officer Form 4 Open market or private purchase of non-derivative or derivative security 404 $2.50 8,404
February 25, 2011 CMO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 70,000 $2.49 255,000
February 25, 2011 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 $2.49 145,000
February 25, 2011 CFO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 70,000 $2.49 170,000
February 25, 2011 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 $2.49 70,000
February 25, 2011 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $2.49 219,911
February 25, 2011 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $2.49 45,000
February 25, 2011 CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 180,000 $2.49 845,000
February 25, 2011 CAO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 16,667 $2.49 38,067
February 25, 2011 Director Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $2.49 157,009
October 3, 2006 VP of Research & Development Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,100 $2.44 9,100
January 3, 2007 President, CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 430,000 $2.42 430,000
January 3, 2007 President, CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 $2.42 480,000
August 15, 2018 Director Form 4 Open market or private purchase of non-derivative or derivative security 2,750 $2.41 12,250
August 9, 2011 Director Form 4 Conversion of derivative security 17,083 $2.40 261,025
March 23, 2011 CMO Form 4 Conversion of derivative security 2,500 $2.40 30,687

For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.